Pfizer Inc

If you haven’t heard of Pfizer over the past couple of years, then you have probably been living off the grid. This century-old powerhouse is one of the world’s leading pharmaceutical and biotechnology companies. You might have heard of the company’s COVID-19 vaccine, but PFE is so much more. Other popular breakthrough drugs the company has developed include Viagra and Lipitor—the best-selling drug in history.

$22.97
(as of Apr 4, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Pfizer Inc

Stock Price
$22.97
Ticker Symbol
PFE
Exchange
NYSE

Industry Information for Pfizer Inc

Sector
Healthcare
Industry
Drug Manufacturers - General

Company Description for Pfizer Inc

Country
USA
Full Time Employees
81,000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Fundamentals for Pfizer Inc

Market Capitalization
$137,759,522,816
EBITDA
$23,321,999,360
Dividends per Share
$1.68
P/E Ratio
17.23
Forward P/E Ratio
8.26
Earnings per Share
$1.41
Earnings per Share Estimate Next Year
Profit Margin
12.62%
Shares Outstanding
5,671,450,112
Percent Owned by Insiders
0.06%
Percent Owned by Institutions
67.52%
52-Week High
52-Week Low

Technical Indicators for Pfizer Inc

50-Day Moving Average
200-Day Moving Average
RSI
23.91
0.6

Analyst Ratings for Pfizer Inc

Strong Buy
8
Buy
3
Hold
13
Sell
0
Strong Sell
1

News About Pfizer Inc

Apr 4, 2025, 10:45 AM EST
We recently published a list of Jim Cramer’s Lightning Round: 8 Stocks in Focus. See more.
Apr 4, 2025, 9:46 AM EST
This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) and the expanded use of AstraZeneca’s AZN blockbuster cancer drug, Imfinzi. See more.
Apr 4, 2025, 9:04 AM EST
For Immediate Release See more.
Apr 4, 2025, 8:00 AM EST
Is Pfizer stock a sell now after HHS fired thousands of employees, putting new drug approvals in limbo? See more.